Stock listing
Lang & Schwarz:A2P7Y0 Hyloris Pharmaceuticals SA Aktie
German listing (Lang & Schwarz) of Hyloris Pharmaceuticals SA · home listing Euronext:HYL
Follow Hyloris Pharmaceuticals SA into a list and get an email when it puts out news.
Home listing price · EURONEXT:HYL
€3.83 EUR -0.03 (-0.8%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:HYL
- Day range
- €3.69 – €3.83 EUROct 30, 2026
- Volume
- 2,583 sharesOct 30, 2026
- Market cap
- €107.2M EURAt the close on Oct 30, 2026 · price × 28.00M shares outstanding
- 52-week range
- €3.38 – €8.40 EURLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- €19,051 EURMedian day 2,191 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:HYL · Home | €3.83 EUR | -0.03 (-0.8%) | 2,583 | €3.72 | €3.83 | €3.69 | €3.86 | Close on Oct 30, 2026 |
| LSE:0AB6 | €4.28 EUR | +0.165 (+4.0%) | 1 | €4.28 | €4.28 | €4.28 | €4.115 | Close on Oct 20, 2026 |
| Frankfurt:52U | €3.75 EUR | -0.01 (-0.3%) | — | €3.75 | €3.75 | €3.75 | €3.76 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · EURONEXT:HYL · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €3.83 | -0.03 | -0.8% | €3.72 | €3.83 | €3.69 | 2,583 | |
| €3.86 | +0.21 | +5.8% | €3.56 | €3.87 | €3.50 | 12,480 | |
| €3.65 | 0.00 | 0.0% | €3.55 | €3.65 | €3.55 | 3,101 | |
| €3.65 | -0.23 | -5.9% | €3.89 | €3.89 | €3.65 | 4,829 | |
| €3.88 | -0.06 | -1.5% | €3.86 | €3.94 | €3.86 | 1,418 | |
| €3.94 | -0.06 | -1.5% | €4.00 | €4.00 | €3.83 | 3,191 | |
| €4.00 | +0.10 | +2.6% | €3.89 | €4.00 | €3.71 | 20,217 | |
| €3.90 | -0.10 | -2.5% | €3.85 | €3.99 | €3.80 | 3,131 | |
| €4.00 | -0.28 | -6.5% | €4.00 | €4.28 | €3.93 | 7,196 | |
| €4.28 | 0.00 | 0.0% | €4.11 | €4.28 | €4.02 | 2,207 | |
| €4.28 | +0.19 | +4.6% | €3.90 | €4.29 | €3.69 | 13,851 | |
| €4.09 | -0.02 | -0.5% | €4.01 | €4.40 | €3.62 | 39,957 | |
| €4.11 | -0.09 | -2.1% | €4.30 | €4.37 | €4.11 | 6,269 | |
| €4.20 | +0.20 | +5.0% | €4.00 | €4.37 | €3.82 | 7,001 | |
| €4.00 | +0.28 | +7.5% | €3.65 | €4.00 | €3.38 | 33,009 | |
| €3.72 | -0.23 | -5.8% | €3.95 | €3.95 | €3.68 | 3,529 | |
| €3.95 | -0.05 | -1.2% | €4.00 | €4.00 | €3.90 | 1,483 | |
| €4.00 | +0.09 | +2.3% | €4.00 | €4.00 | €3.90 | 1,572 | |
| €3.91 | -0.17 | -4.2% | €4.00 | €4.09 | €3.81 | 10,364 | |
| €4.08 | -0.12 | -2.9% | €4.20 | €4.20 | €4.08 | 1,745 | |
| €4.20 | -0.05 | -1.2% | €4.25 | €4.25 | €4.20 | 1,009 | |
| €4.25 | -0.06 | -1.4% | €4.21 | €4.25 | €4.11 | 6,447 | |
| €4.31 | -0.07 | -1.6% | €4.38 | €4.38 | €4.31 | 912 | |
| €4.38 | +0.03 | +0.7% | €4.37 | €4.45 | €4.37 | 4,772 | |
| €4.35 | -0.10 | -2.2% | €4.50 | €4.50 | €4.35 | 5,200 | |
| €4.45 | -0.14 | -3.1% | €4.50 | €4.56 | €4.42 | 6,863 | |
| €4.59 | +0.29 | +6.7% | €4.50 | €4.81 | €4.34 | 24,541 | |
| €4.30 | +0.25 | +6.2% | €4.07 | €4.35 | €4.07 | 733 | |
| €4.05 | -0.15 | -3.6% | €4.19 | €4.20 | €4.05 | 2,821 | |
| €4.20 | 0.00 | 0.0% | €4.20 | €4.20 | €4.10 | 894 | |
| €4.20 | -0.02 | -0.5% | €4.20 | €4.22 | €4.11 | 4,607 | |
| €4.22 | -0.03 | -0.7% | €4.25 | €4.35 | €4.20 | 2,448 | |
| €4.25 | +0.01 | +0.2% | €4.25 | €4.25 | €4.24 | 435 | |
| €4.24 | +0.04 | +1.0% | €4.20 | €4.24 | €4.20 | 215 | |
| €4.20 | -0.05 | -1.2% | €4.20 | €4.20 | €4.20 | 2,175 | |
| €4.25 | -0.01 | -0.2% | €4.25 | €4.32 | €4.25 | 455 | |
| €4.26 | -0.04 | -0.9% | €4.30 | €4.35 | €4.26 | 1,456 | |
| €4.30 | -0.05 | -1.1% | €4.35 | €4.40 | €4.30 | 466 | |
| €4.35 | -0.05 | -1.1% | €4.40 | €4.40 | €4.35 | 848 | |
| €4.40 | -0.09 | -2.0% | €4.55 | €4.55 | €4.40 | 319 | |
| €4.49 | 0.00 | 0.0% | €4.49 | €4.50 | €4.49 | 152 | |
| €4.49 | -0.06 | -1.3% | €4.60 | €4.60 | €4.49 | 1,024 | |
| €4.55 | +0.06 | +1.3% | €4.25 | €4.55 | €4.25 | 6,140 | |
| €4.49 | +0.09 | +2.0% | €4.41 | €4.49 | €4.40 | 6,511 | |
| €4.40 | -0.02 | -0.5% | €4.40 | €4.49 | €4.40 | 1,125 | |
| €4.42 | +0.06 | +1.4% | €4.36 | €4.42 | €4.36 | 527 | |
| €4.36 | -0.03 | -0.7% | €4.39 | €4.40 | €4.36 | 1,290 | |
| €4.39 | -0.01 | -0.2% | €4.39 | €4.40 | €4.38 | 1,110 | |
| €4.40 | -0.06 | -1.3% | €4.46 | €4.48 | €4.40 | 4,777 | |
| €4.46 | -0.04 | -0.9% | €4.43 | €4.49 | €4.42 | 1,627 | |
| €4.50 | +0.05 | +1.1% | €4.45 | €4.50 | €4.45 | 1,555 | |
| €4.45 | -0.05 | -1.1% | €4.44 | €4.49 | €4.44 | 295 | |
| €4.50 | +0.07 | +1.6% | €4.44 | €4.55 | €4.43 | 2,191 | |
| €4.43 | -0.06 | -1.3% | €4.43 | €4.49 | €4.43 | 843 | |
| €4.49 | -0.02 | -0.4% | €4.50 | €4.50 | €4.43 | 1,065 | |
| €4.51 | -0.13 | -2.8% | €4.60 | €4.64 | €4.51 | 1,748 | |
| €4.64 | -0.06 | -1.3% | €4.78 | €4.78 | €4.64 | 823 | |
| €4.70 | +0.20 | +4.4% | €4.50 | €4.78 | €4.40 | 4,257 | |
| €4.50 | -0.03 | -0.7% | €4.63 | €4.63 | €4.45 | 2,742 | |
| €4.53 | -0.03 | -0.7% | €4.53 | €4.67 | €4.53 | 81 | |
| €4.56 | +0.05 | +1.1% | €4.55 | €4.80 | €4.55 | 4,937 | |
| €4.51 | -0.19 | -4.0% | €4.68 | €4.68 | €4.51 | 2,716 | |
| €4.70 | +0.19 | +4.2% | €4.52 | €4.70 | €4.50 | 2,809 | |
| €4.51 | -0.20 | -4.2% | €4.70 | €4.70 | €4.51 | 1,461 | |
| €4.71 | -0.07 | -1.5% | €4.78 | €4.78 | €4.65 | 213 | |
| €4.78 | -0.01 | -0.2% | €4.79 | €4.79 | €4.57 | 659 | |
| €4.79 | +0.09 | +1.9% | €4.70 | €4.79 | €4.51 | 4,481 |
- Ticker
- Lang & Schwarz:A2P7Y0
- Asset type
- Stock
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Sep 28, 2026
Consolidated 2026 Half-Year Report: Hyloris Delivers 56% Revenue Growth and Its Lowest Half-Year Net Loss Since IPO, Advances Its Mavericks, Core Drivers and Promising Seeds
Latest deck · Oct 13, 2026
Investor Presentation (October 2026)
Investor deck · 27 slides
Latest news
Consolidated 2026 Half-Year Report: Hyloris Delivers 56% Revenue Growth and Its Lowest Half-Year Net Loss Since IPO, Advances Its Mavericks, Core Drivers and Promising Seeds
Sep 28, 2026
Closed €4.35 (-2.2%) on Sep 28, 2026
Hyloris Pharmaceuticals: Regulated Information Hyloris’ Annual General Shareholders Meeting on June 9, 2026 ENGLISH VERSION
May 8, 2026
Closed €5.16 (-1.9%) on May 8, 2026
Hyloris Pharmaceuticals: Regulated Information Hyloris releases Annual Report 2025 ENGLISH VERSION
Apr 30, 2026
Closed €5.12 (+5.6%) on May 4, 2026
Consolidated Results 2025 - Hyloris Achieves Strong Royalty Growth and Portfolio Expansion with Solid Cash Position: a year of bold moves and breakthrough milestones
Mar 26, 2026
Closed €5.28 (-4.0%) on Mar 26, 2026
Hyloris Pharmaceuticals: Inside Information Hyloris Provides Update on FDA Review of Valacyclovir for Oral Suspension ENGLISH VERSION
Feb 19, 2026
Closed €7.00 (-4.1%) on Feb 19, 2026
Hyloris Pharmaceuticals Provides Update on FDA Review of Valacyclovir for Oral Suspension
Feb 19, 2026
Closed €7.00 (-4.1%) on Feb 19, 2026
Disclosure of a received transparency notification in accordance with article 14 of the act of 2 May 2007 on disclosure of large shareholdings
Feb 2, 2026
Closed €7.52 (-2.8%) on Feb 3, 2026
Hyloris Pharmaceuticals Announces Strategic Partnership with Orion for its RTU Pantoprazole IV in European Markets
Jan 19, 2026
Closed €7.60 (-0.3%) on Jan 20, 2026
Licenses European and Turkish Rights to Next-Generation Wilson’s Disease Candidate from ArborMed
Dec 30, 2025
Closed €6.84 (+8.2%) on Dec 31, 2025
Decks
Investor Presentation (October 2026)
Investor deck · 27 slides · Oct 13, 2026
H1 2026 Earnings Presentation
Earnings · 43 slides · Sep 24, 2026
Shareholder Meeting (June 2026)
Shareholder meeting · 48 slides · Jun 9, 2026
Investor Presentation (April 2026)
Investor deck · 42 slides · Apr 1, 2026
Hyloris Pharmaceuticals SA on 6ix
- News releases
- 13 in the last 12 months · 16 in all · newest Sep 28, 2026 · oldest 2025
- Decks
- 30 decks · latest Oct 13, 2026
Where Hyloris Pharmaceuticals SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:HYL · Home listing | Euronext | Belgium | EUR |
| Lang & Schwarz:A2P7Y0 · This page | Lang & Schwarz | Germany | EUR |
| LS Exchange:A2P7Y0 | LS Exchange | Germany | EUR |
| LSE:0AB6 | LSE | United Kingdom | EUR |
| Stuttgart:52U | Stuttgart | Germany | EUR |
| Turquoise:HYLB | Turquoise | United Kingdom | EUR |
| Frankfurt:52U | Frankfurt | Germany | EUR |
| Dusseldorf:52U | Dusseldorf | Germany | EUR |
Log in to ask 6ix AI your own questions about Hyloris Pharmaceuticals SA.